12
Participants
Start Date
March 31, 2010
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Erchonia MLS + Erchonia THL
"The Erchonia® MLS is administered weekly for 6 continuous weeks at the test site by the study investigator.~The Erchonia THL is administered twice daily for 6 continuous weeks (42 days) at home by the subject.~Administration of the MLS and the THL occur simultaneously over the 6-week administration phase.~The intent is to evaluate the effectiveness of Erchonia MLS \& Erchonia THL when administered together, and not to compare Erchonia MLS vs. Erchonia THL"
Westlake Dermatology, Austin
Lead Sponsor
Erchonia Corporation
INDUSTRY